The naica® system, a flexible digital PCR solution for assay development: application to wastewater-based epidemiology of COVID-19.
Stilla Technologies has introduced into the market the naica® system, using Crystal Digital PCR™ technology for the precise and highly sensitive quantification of nucleic acids. This powerful, yet easy-to-use digital PCR (dPCR) platform is the highest-plexing dPCR instrument available, with six fluorescent channels used to detect multiple genetic targets in a single run.
Scientists devoted to immuno-oncology are establishing new ways to target and destroy cancer cells through personalized immunotherapies. Thanks to decades of research and advances in technologies, scientists have richly documented the human adaptive and innate immune response mechanisms and are now using that information to design and administer personalized immunotherapies.
Today’s lab is a high data throughput environment. Nearly all of your equipment is capturing data, and key analytical systems are capturing more data than ever before. As the pace, volume and variety of data increase, the use of analytics has become essential to creating operational efficiencies
With SARS-CoV2, many people were left wondering about the need for multiple shots, whereas certain vaccines, such as the vaccine for yellow fever, require only one shot in our lifetime. In short, it’s due to a combination of escape variants and dropping levels of antibodies allows for reinfection.
The COVID-19 pandemic has driven global pharmaceutical companies to reevaluate and transform their supply chain processes. One increasingly preferred approach is by outsourcing research and manufacturing to external service providers, to reduce costs and maximize manufacturing scalability.
A well-established public health institute in Thailand, specializing in antivenom serums and vaccines, was able to increase its capacity to produce freeze-dried vaccines and prolong serums’ shelf-life thanks to an industry-leading freeze-dryer supplied by DKSH.
SPR assays are a gold standard in biologics research and development of safe and effective treatments against disease. The data derived from SPR can aid us in better understanding molecular mechanisms while providing inishgt into key signaling pathways and advancing drug development. Join us for this webinar to learn about the advantages of OpenSPR in immunotherapy, plant-based medicines and drug development.
Ibidi is a leading supplier of functional cell-based assays and advanced products for cellular microscopy that enable scientists to tackle the underlying mechanisms of major illnesses such as cancer, cardiovascular conditions, and autoimmune diseases.
The University of Technology in Sydney (UTS) collaborated with DKSH to research advanced cellular biology to better understand the effects of microgravity on cancer cells.
Delivering Growth – in Asia and Beyond.
© DKSH International Ltd.
Please enter your details here:
